Latest Market Expansion News

Range International Limited delivered a standout Q4 2024 with record sales revenue from its Re>Pal Indonesia operations, alongside improved margins and positive cash flow, signaling a robust turnaround.

Bell Financial Group has secured a significant agreement with Macquarie Bank to transfer approximately 75,000 online trading accounts, positioning Bell Direct and Desktop Broker for growth and earnings uplift in FY 2025.

Compumedics has locked in a pivotal five-year contract with Philips Australia, cementing Somfit as the leading device for pharmacy-based sleep testing and underpinning significant SaaS revenue growth through 2028.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

First Graphene Limited strengthens its financial footing with a UK R&D tax rebate and expands its global footprint through new distribution agreements in India and Brazil.

Thrive Tribe Technologies has appointed Jade Spooner as CEO to spearhead the rapid commercialisation of its Kumu platform and e-commerce marketplace. Spooner’s proven track record in scaling tech startups positions her to lead 1TT into its next growth phase.

Respiri Limited has completed its acquisition of Orb Health Inc. for US$9 million in shares, marking a strategic move to strengthen its foothold in the US connected and chronic care market. The integration promises operational cost savings and expanded service offerings.

PolyNovo Limited reports a robust 22.8% revenue increase in 1H FY25, driven by strong U.S. and international sales growth and progressing FDA approval efforts for its NovoSorb platform.

RLF AgTech has secured a strategic trading agreement with National Rural Independent Ltd, enabling distribution of its crop nutrition products through 152 stores nationwide, marking a pivotal step in its Australian market expansion.

Connexion Mobility reports robust Q2 FY25 results with revenue and net profit surging, driven by subscription growth and strategic product launches. The company’s focus on user engagement and marketplace expansion signals promising long-term shareholder value.

Memphasys Limited has secured a major scientific endorsement for its RoXsta™ antioxidant profiling system, positioning the technology for expanded clinical and agricultural applications.

Orthocell Limited has reported a third consecutive quarter of record revenue, driven by strong sales growth and strategic market expansions, including a key US FDA submission for its nerve repair product Remplir™.